Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 903 | 1,636 | 653 | 573 | 1,324 |
Cost of Goods | 275 | 552 | 181 | 254 | 184 |
Gross Profit | 628 | 1,084 | 472 | 320 | 1,140 |
Operating Expenses | 4,856 | 4,046 | 4,075 | 4,021 | 4,245 |
Operating Income | -3,953 | -2,410 | -3,422 | -3,447 | -2,921 |
Other Income | -8 | -5 | 55 | -20 | -6 |
Pre-tax Income | -3,961 | -2,415 | -3,367 | -3,468 | -2,926 |
Net Income Continuous | -3,961 | -2,415 | -3,367 | -3,468 | -2,926 |
Net Income | $-3,961 | $-2,415 | $-3,367 | $-3,468 | $-2,926 |
EPS Basic Total Ops | -128.00 | -80.00 | -112.00 | -112.00 | -104.00 |
EPS Basic Continuous Ops | -124.64 | -80.15 | -111.88 | -115.24 | -103.85 |
EPS Diluted Total Ops | -128.00 | -80.00 | -112.00 | -112.00 | -104.00 |
EPS Diluted Continuous Ops | -124.64 | -80.15 | -111.88 | -115.24 | -103.85 |
EBITDA(a) | $-3,791 | $-2,261 | $-3,254 | $-3,276 | $-2,702 |